Are you Dr. Karakas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Cansu Karakas, MD is a board certified pathologist in Stanford, California. She is currently licensed to practice medicine in California and Massachusetts. She is affiliated with Stanford Health Care.
Certifications & Licensure
- CA State Medical License 2024 - 2026
- MA State Medical License 2023 - 2026
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer.Mi Li, Amriti R Lulla, Yan Wang, Spyros Tsavaschidis, Fuchenchu Wang
Cancer Research. 2024-11-15 - 4 citationsNeutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis.Amriti R Lulla, Said Akli, Cansu Karakas, Joseph A Caruso, Lucas D Warma
Molecular Cancer Therapeutics. 2024-04-02 - 1 citationsIn ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistoc...Haley Tyburski, Cansu Karakas, Brian S Finkelman, Bradley M Turner, Huina Zhang
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2024-03-01